EVGN News

Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases

AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities

Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery

EagleVision's 'Nature, Inc.' Spotlights Jeff Perry Who Saved 1,000+ Burned Trees to Help Rebuild Altadena

EagleVision Entertainment Corporation Launches Nature, Incorporated (Nature, Inc.): Uncut Stories Highlighting Nature's Wisdom

Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization

Evogene to Present Its Pharma Division Achievements at the BIO International Convention

Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica

Evogene Reports First Quarter 2026 Financial Results

Evogene to Present at the 24th Schrödinger European User Group Meeting